Cargando…

Holistic management of symptomatic reflux: rising to the challenge of proton pump inhibitor overuse

Detalles Bibliográficos
Autores principales:	Savarino, Edoardo, Anastasiou, Foteini, Labenz, Joachim, Hungin, A Pali S, Mendive, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Royal College of General Practitioners 2022
Materias:	Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9591095/ https://www.ncbi.nlm.nih.gov/pubmed/36302677 http://dx.doi.org/10.3399/bjgp22X721157

Ejemplares similares

Management advice for patients with reflux-like symptoms: an evidence-based consensus
por: Hungin, A. Pali, et al.
Publicado: (2023)

Review article: rethinking the “ladder” approach to reflux‐like symptom management in the era of PPI “resistance” ‐ a multidisciplinary perspective
por: Hungin, A. Pali S., et al.
Publicado: (2022)

Evaluation of symptomatic reflux esophagitis in proton pump inhibitor users
por: Asaoka, Daisuke, et al.
Publicado: (2019)

Symptoms, the GerdQ score and patients’ characteristics do not predict gastroesophageal reflux disease in patients with proton-pump-inhibitor-refractory reflux symptoms—results from a large prospective database
por: Labenz, Joachim, et al.
Publicado: (2023)

Use and overuse of proton pump inhibitors
por: Staiano, Annamaria, et al.
Publicado: (2015)

High-resolution Manometry Determinants of Refractoriness of Reflux Symptoms to Proton Pump Inhibitor Therapy
por: Ribolsi, Mentore, et al.
Publicado: (2020)

On-demand Versus Continuous Maintenance Treatment of Gastroesophageal Reflux Disease With Proton Pump Inhibitors: A Systematic Review and Meta-analysis
por: Kang, Seung Joo, et al.
Publicado: (2022)

Setting a research agenda for medical overuse
por: Morgan, Daniel J, et al.
Publicado: (2015)

A Systematic Review and Meta-analysis of Randomized Control Trials: Combination Treatment With Proton Pump Inhibitor Plus Prokinetic for Gastroesophageal Reflux Disease
por: Jung, Da Hyun, et al.
Publicado: (2021)

Overuse of Reflux Medications in Infants
por: Wolf, Elizabeth R., et al.
Publicado: (2023)

Hormone replacement therapy is associated with gastro-oesophageal reflux disease: a retrospective cohort study
por: Close, Helen, et al.
Publicado: (2012)

Efficacy of proton pump inhibitors and H2 blocker in the treatment of symptomatic gastroesophageal reflux disease in infants
por: Azizollahi, Hamid Reza, et al.
Publicado: (2016)

Analyses of inequalities in RMNCH: rising to the challenge of the SDGs
por: Victora, Cesar, et al.
Publicado: (2019)

Epidemiological Study Assessing the Overuse of Proton Pump Inhibitors in Lebanese Population
por: Hoteit, Mayssaa, et al.
Publicado: (2020)

Management of laryngopharyngeal reflux with proton pump inhibitors
por: Reimer, Christina, et al.
Publicado: (2008)

Pathophysiological Studies Are Mandatory to Understand the Benefit of Proton Pump Inhibitors in Patients with Idiopathic Pulmonary Fibrosis
por: Savarino, Edoardo, et al.
Publicado: (2016)

Quick fix for care, productivity, hygiene and inequality: reframing the entrenched problem of antibiotic overuse
por: Denyer Willis, Laurie, et al.
Publicado: (2019)

Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions
por: Mermelstein, Joseph, et al.
Publicado: (2018)

Proton pump inhibitor use is associated with a variety of infections in patients with liver cirrhosis
por: Labenz, Christian, et al.
Publicado: (2020)

Overdiagnosis paradigm: not suitable for decreasing the overuse of antibiotics
por: Cordoba, Gloria, et al.
Publicado: (2019)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

Novel impedance‐pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro‐oesophageal reflux disease according to Lyon Consensus
por: Ribolsi, Mentore, et al.
Publicado: (2021)

Knowledge gaps in the management of refractory reflux‐like symptoms: Healthcare provider survey
por: Armstrong, David, et al.
Publicado: (2022)

Impedance-detected Symptom Association and Number of Reflux Episodes as Pre-treatment Parameters That Predict Outcomes of Gastroesophageal Reflux Disease Patients
por: Savarino, Edoardo, et al.
Publicado: (2015)

Proposed approach to the challenging management of progressive gastroesophageal reflux disease
por: Labenz, Joachim, et al.
Publicado: (2018)

China’s response to the rising stroke burden
por: Li, Zixiao, et al.
Publicado: (2019)

Helicobacter pylori, proton pump inhibitors and gastroesophageal reflux disease.
por: Kuipers, E. J., et al.
Publicado: (1999)

Distinction between patients with non-erosive reflux disease and functional heartburn
por: Giacchino, Maria, et al.
Publicado: (2013)

Proton pump inhibitors and adverse effects in kidney transplant recipients: A meta-analysis
por: Boonpheng, Boonphiphop, et al.
Publicado: (2019)

Exposure to proton pump inhibitors and risk of diabetes: A systematic review and meta-analysis
por: Guo, Yun-Ran, et al.
Publicado: (2023)

Governing multisectoral action for health in low-income and middle-income countries: unpacking the problem and rising to the challenge
por: Bennett, Sara, et al.
Publicado: (2018)

Role of Acid and Weakly Acidic Reflux in Gastroesophageal Reflux Disease Off Proton Pump Inhibitor Therapy
por: Sung, Hea Jung, et al.
Publicado: (2012)

The daily response for proton pump inhibitor treatment in Japanese reflux esophagitis and non-erosive reflux disease
por: Shida, Hiroshi, et al.
Publicado: (2013)

Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis
por: Trifan, Anca, et al.
Publicado: (2017)

Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease
por: Shi, Yi-Chao, et al.
Publicado: (2019)

Meta-analysis of the efficacy of proton pump inhibitors for the symptoms of laryngopharyngeal reflux
por: Liu, C., et al.
Publicado: (2016)

Meta-analysis of Proton Pump Inhibitors in the Treatment of Pharyngeal Reflux Disease
por: Jin, Xiulin, et al.
Publicado: (2022)

Association of proton pump inhibitors with risk of hepatic encephalopathy in advanced liver disease: A meta-analysis
por: Tantai, Xin-Xing, et al.
Publicado: (2019)

Association between proton-pump inhibitors and the risk of gastric cancer: a systematic review with meta-analysis
por: Segna, Daniel, et al.
Publicado: (2021)

Efficacy of Vonoprazan for Gastroesophageal Reflux Symptoms in Patients with Proton Pump Inhibitor-resistant Non-erosive Reflux Disease
por: Niikura, Ryota, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_llon3m4mdcoca0bip3vj068oi1